SlideShare una empresa de Scribd logo
1 de 175
Descargar para leer sin conexión
LD TECHNOLOGY SYMPOSIUM CANCUN 2008
Welcome to LD TECHNOLOGY  We are listening the body signals < < <
Medical devices Positioning  Diagnosis /Monitoring  GENERAL INFORMATION’S ACCURACY
DIAGNOSIS DEFINITION* Diagnosis is the identification, by process of elimination, of the nature of anything. *Wikipedia
Process of elimination in medical diagnosis Clinical context : signs, symptoms, history, current treatments……………….. Specific Examinations : Medical devices ,[object Object]
In vitro Laboratory tests
In vivo Physiological measurements.Physician’s Knowledge and interpretation
Medical devices ,[object Object]
A medical device do not make a diagnosis, only a Physician can make a diagnosis.
According to the investigation site, each medical device is providing specific indicators in same or different direction.
 The cross analysis of all indicators are necessary in the process of elimination for diagnosis and interpretation and knowledge of the physician,[object Object]
Specificity and sensitivity
Diagnosis are hypothesis After  the process of elimination , the  cross analysis of the clinical context and supplementary examinations , the physician make a hypothesis of diagnosis: because the human body is a complex of balance and all the dysfunctions or diseases have implications in all the body systems
Treatment choice Hypothesis of diagnostic Adapted Treatment of the diagnosed diseases issues from the clinical investigations   Improvement  of the results of the supplementary examinations  No Improvement  of the results of the supplementary examinations  MONITORING Improvement  of the clinical context Or Improvement or no  improvement  of the clinical context Side effect  over the benefits of the treatment No validation , misdiagnosis or no responses dues to  inter individual difference  Validation of the diagnosis hypothesis
EIS SYSTEM TECHNOLOGY FEATURES BACKGROUND
EIS Measurement
EIS SYSTEM Features  : Impedance plethysmography 1.Measurement of the conductivity in DC* of  22 segments of the human body.  *The conductivity in DC ( way from anode (+) to cathode (-) ) is proportional with the :  ,[object Object]
I.S.F Ionic concentration and in particular the Na+ concentration
Blood flow Conductivity measurement accuracy +/-3.5% 2. Modeling** of the Human body according to the conductivity of the 22 segments by mathematical application of the Venn diagram and the normal positioning extrapolation of the body systems. **Accuracy of the modeling  ( p<0.001) for the cerebral frontal lobes, digestive system Prostate and thyroid.
EIS Features Sequence  of the measurement of the 22 body segments ESG graphic: conductivity of the 22 segments ESG normal range values
EIS Features (2) Min C O N D U C T I V I T Y Venn diagram calculation Max Modeling  Maxwell equation’ s calculation
EIS / EFFECT OF THE DC CURRENT IN INTERSTITIAL FLUID Na+ The  current is carrier by the ions . The Current is sending from the Anode (+) to Cathode (-) , and therefore the Na+ ( most significant concentration of positive ions in the IF)  are moving to the negative pole . The conductivity is proportionally  increased with the Na+ concentration and the volume of the interstitial fluid   Na+ Na+ Na+ Na+ 1.28 V
Na+/K+ pump Na+/H+ anti porterNa+/ATP  Production Na+ Na+ Na+ Na+ Na+ H+ Na+ Na+ Na+ Na+ Na+ ATP
Interstitial fluid volume and Oxygen delivery Effect of inter capillary distance on relation between oxygen delivery BMJ. 1998 November 14; 317(7169): 1370–1373. Copyright © 1998, British Medical Journal
EIS MODELING PARAMETERS  ,[object Object],Related with the Oxygen delivery and osmotic/ hydrostatic pressure ,[object Object],Related with [K+] (2/3), [H+] and ATP production.  ,[object Object],Related with the Blood viscosity and the Blood velocity.
EIS –BF SYSTEM  CLINICAL INVESTIGATIONS UPDATE VERSION 10
EIS- BF Clinical Investigations Accuracy for Monitoring of the following treatment (p< 0.001) : Sp 94% No sensitivity Thyroid substitute treatment Hypo tensors ( Beta blockers and CEI) Anticoagulants Antidepressants SSRI Accuracy in Adjunct in conventional diagnosis of the ADHD children: (p< 0.0001) :  Sp 95% / Se 78%
Visit 1 : No treatment Visit 2: Dosage 100 µg Visit 3: Dosage 120 µg Visit 4: Dosage 150 µg Visit 5: Dosage 100 µg Thyroid value in EIS Modeling  Visit 1 :-40                      Visit 2: -10 Visit 3: 0 Visit 4: +20 Visit 5: -5 N=52 (r=0.79, P<0.001, and r=0.80, P<0.001, respectively). TSH measured in lab tests Visit 1 Visit 2: 6 Visit 3: 3 Visit 4: 0 Visit 5: 2 N=52 (r=0.81, P<0.001, and r=0.73, P<0.001, respectively).
N=52 (r=0.79, P<0.001, and r=0.80, P<0.001,). N=52 (r=0.79, P<0.001, and r=0.80, P<0.001,).
N=52 (r=0.79, P<0.001, and r=0.80, P<0.001,). N=52 (r=0.79, P<0.001, and r=0.80, P<0.001,).
N=52 (r=0.79, P<0.001, and r=0.80, P<0.001,). N=52 (r=0.79, P<0.001, and r=0.80, P<0.001,).
ADHD Children Profile
EIS BF Results Version 10
Digestive system Indicators
Brain Indicators
Cardiovascular Indicators
HORMONAL INDICATORS
RESPIRATORY INDICATORS
General metabolic indicators
Uro genital and renal indicators
Follow up of all the indicators
Medications monitoring indicators
Antidepressant (SSRI) Follow up Before treatment Response No response
Follow up of the Cerebral neurotransmitters
Medications monitoring indicators
Follow up of thyroid treatment Monitoring and  results Before treatment Over doses Under doses
Medications monitoring indicators
Anti agregants and anticoagulants follow up Before treatment Effective treatment No effective
Medications monitoring indicators
Beta blockers follow up  Before treatment No effective treatment Overdosis and side effects Good treatment
CEI Follow up Before treatment Good treatment Overdose and side effect No effective
ADHD Children profile and diagnosis in adjunct with the clinical context
Indicator of ADHD Children Lack Dopamine and Serotonin and signs and symptoms from clinical context children less 17 y.o
EIS POSITIONING QUALITY SYSTEM IN MEDECINE
EIS System: May be a possibility for help the quality system requirements in medicine
Positioning of the EIS in the Quality System Requirements EIS SYSTEM  ADHD
Why a quality system with the EIS System ,[object Object]
For the patient : Understanding of the treatment and goal of the treatment
For the practitioner Early visualization of the therapies and early possibility of corrective action
Because a disease treatment requires drug, sometime surgery and always lifestyle change
Because , the major diseases cannot be treated by lifestyle change or alternative medicine. ,[object Object]
Organization , save time
 Better understanding of the intended use   and side effects of the treatments used
Corrective actions that the patient can understand
Referrals
Income increased,[object Object]
New products EIS BWS: Wellness and lifestyle  ES Teck: Estimated of the ANS activity and of cardiovascular indicators. 510k in progress     Nr K083229 ES Teck Complex : Combination EIS /ES Teck ITM Breast imaging by electro impedance.
EIS New application : BSW (Body Scan Wellness) Why BSW? Because  There is not good or bad diet for every people, there is good or bad diet for each person The change of nutrition need to be monitoring and the good nutrition for each person is not available all his life. Based on the EIS and BC device measurement
Why the E S Teck  Because  HRV ( ANS activity estimation)  Photoelectrical Plethysmograph ( Vascular estimation) body composition and the phase Angle measurement Can give new indicators in the process of elimination of the physician’s diagnosis
Why the ES Teck Complex Combination of the EIS and the ES Teck: Because : The cross analysis of the indicators issue from 4 different technologies will increase the sensitivity and therefore the accuracy of a medical device
Why the ITM ,[object Object]
The positive predictive value of mammography for breast cancer ranges from 20% in women under age 50.
The tissue conductivity has a high sensitivity (> 80%) for the cancer.
The ITM  as an adjunct to mammography in patients who have equivocal mammographic findings within ACR BI-RADSTM categories 3 or 4 provides the radiologist with additional information to guide a biopsy recommendation and increase the sensitivity of the examination from 20 % to 80 % in women under age 50.,[object Object]
BWS Measurement
BSW Results
Body Composition
Nutritional and micro nutrional program Analysis
Nutritional Analysis ReportAll results should be considered in the clinical context of the patient's case history, symptoms, known diagnosis, current medications, treatment plan and therapies. This diet analysis does not replace the advice of your practitioner.The estimated body composition is made according to the James equation and the formulas from the peer reviews.
Nutritional Analysis Report (2)
Body Composition Follow up
ES TECK SYSTEM GENERAL INFORMATION’S
ES Teck System (Cardiology) HRV                   Photoelectrical Plethysmograph
HRV ( short time)  HRV Reference:  Task Force of The European Society of Cardiology and The North American Society of Pacing and Electrophysiology (1996)
SpO2 and Photoelectrical Plethysmograph References: ,[object Object]
Takazawa, Kenji; Tanaka, Nobuhiro; Fujita, Masami; Matsuoka, Osamu; Saiki, Tokuyu; Aikawa, Masaru; Tamura, Sinobu; Ibukiyama, Chiharu :Assessment of Vasoactive Agents and Vascular Aging by the Second Derivative of Photoplethysmogram Waveform Hypertension: Volume 32(2)August 1998pp 365-370
IToshiaki OTSUKA , Tomoyuki KAWADA , Masao KATSUMATA , Chikao IBUKI , and Yoshiki KUSAMA ndependent Determinants of Second Derivative of the Finger Photoplethysmogram among Various Cardiovascular Risk Factors in Middle-Aged Men Hypertens Res Vol. 30, No. 12 (2007)
Toshiaki Otsuka, , Tomoyuki Kawada, Masao Katsumata,ChikaoIbuki, :Utility of Second Derivative of the Finger Photoplethysmogram for the Estimation of the Risk of Coronary Heart Disease in the General Population Circ J 2006; 70: 304 – 310
Alberto Avolio: The finger volume pulse and assessment of arterial properties .Journal of Hypertension 2002, 20:2341–2343
Oximeter Guidelines 1998,[object Object]
 Heart Rate and sinus node depolarization
Autonomic Nervous System and Heart rate variability
SpO2 AND Photoelectrical Plethysmography SpO2 Probe  Infra red/ Red  660/905 nm Photo diode SpO2% PR Vascular  waves
SpO2 ANALYSIS Oxygen - hemoglobin Affinity Changes. The functions of hemoglobin are oxygen pickup and delivery. The hemoglobin has an affinity (the strength of bond between oxygen and hemoglobin) that can be increased or decreased due to various situations. If hemoglobin has an increased affinity, it is highly saturated; but oxygen is less available for release to the tissues due to the strong bond. The reverse is also true.
Vascular Wave Analysis
Analysis by Acceleration and Second derivative
Analysis of the Second derivative with age
Analysis of the second derivative and diseases : b/a
Analysis of the second derivative and diseases : d/a
Specificity and sensitivity of the b/a and d/a indicators
Specificity and sensitivity of the b/a and d/a indicators Ref. Toshiaki OTSUKA , Tomoyuki KAWADA , Masao KATSUMATA , Chikao IBUKI , and Yoshiki KUSAMA Independent Determinants of Second Derivative of the Finger Photoplethysmogram among Various Cardiovascular Risk Factors in Middle-Aged Men Hypertens Res Vol. 30, No. 12 (2007)
Results  of ES Teck
HRV  STATISTICAL RESULTS
SpO2 and Photoelectrical Plethysmograph results
E.S TECK COMPLEX GENERAL INFORMATION’S
ES TECK COMPLEX  THE NATURAL EIS UPDATE
ES Teck Complex Measurements
CROSS ANALYSIS
E.S TECK COMPLEX  INTENDED USES ,[object Object]
It only provides numerical analyses of the input electrocardiogram.
Estimate of the parasympathetic and sympathetic system stimulation.
PP module: Analyze the pulse waveform by photoelectric plethysmography and Pulse rate.
Evaluation of Large and small artery
EIS module:
Monitoring of diseases, functional  and lifestyle ‘ treatments
Adjunct to conventional diagnosis of ADHD children
BIA module :
Calculation and Historical Tracking of body composition,[object Object]
Resistance and Reactance measurements  Resistance is a measure of how difficult it is for electricity to flow through an object. Reactance Most objects have some capacitance, which is a measure of ability to store an electrical charge. The more capacitance the object has, or the faster the current changes direction, the less the object will “react” to the current.  
EIS B I A Peer reviews formula  ,[object Object],5-19 y.o Davies et al 1988 20-80 y.o  Lukaski and Bolonchuk 1988  Adult obese subjects: Segal et al 1988  ,[object Object],7-15 y.o  Deurenberg et al 1991  16-83 y.o  Deurenberg et al 1991 ,[object Object],Sergi G, et al 1994
Phase Angle
Impedance Components Phase Angle Xc = 1 / (2 * PI * F * C),     C – Capacity [Farad] Phase Angle = Arctan (Xc / R)
Clinical application in survival in colorectal cancer  The survival curves for the 2 categories of phase angle areshown. Patients with a phase angle < 5.57 had a mediansurvival of 8.6 mo (95% CI: 4.8, 12.4; n = 26), and those witha phase angle > 5.57 had a median survival of 40.4 mo (95%CI: 21.9, 58.8; n = 26); this difference was significant (P= 0.0001).
Impact of phase angle in liver cirrhosis
NEW INTERFACE
E.S TECK RESULTS
EIS ANALYSIS
HRV STATISTICAL RESULTS
HRV RECORDS
HRV GEOMETRICAL ANALYSIS
SpO2 RESULTS AND MANAGEMENT OF THE PHOTOELECTRICAL WAVE
PHOTOELECTRICAL PLETHYSMOGRAPH ANALYSIS AND RESULTS
Vascular Indicators  PH : Relation with blood flow of small artery    EEI : Relation with LV ejection and elasticity of large artery  - LV Ejection Insufficiency DDI : Relation with contraction and tension of small artery - Hypertension & Arteriosclerosis DEI : Relation with blood flow to vein system.  Etc (Estimated Cardiac Ejection time) : 260~380  Function of left ventricle
BODY COMPOSITION RESULTS
Body Composition follow up
E.S TECK COMPLEX ,[object Object]
MODELING AND BODY SYSTEMS’ INDICATORS,[object Object]
BRAIN INDICATORS
CARDIOVASCULAR INDICATORS
HORMONAL INDICATORS
RESPIRATORY SYSTEM INDICATORS
GENERAL METABOLIC INDICATORS
UROGENITAL AND RENAL INDICATORS
Follow up of all the indicators
Follow up of the Cerebral neurotransmitters
Medications monitoring indicators
Medications monitoring indicators
Medications monitoring indicators
Medications monitoring indicators
ADHD Children profile and diagnosis in adjunct with the clinical context
Chiropractor  Indicators and monitoring treatment
Advices for Lifestyle and exercises and monitoring
Advices for Lifestyle and exercises and monitoring
Advices for Lifestyle and exercises and monitoring
Exercises
Sport men condition Evaluation and improvement
Statistical risk analysis No access before 5  measurements. The accuracy increased with the number of measurements. Statistical analysis of the indicators of each body systems and metabolic general indicators It is not a diagnosis , but help for the physician in the process of elimination
I.T.M Impedance Tomography Mammography GENERAL INFORMATION’S
ITM ADJUNCT TO THE MAMMOGRAPHY BI-RADS
MAMOGRAPHY IMAGES AND MRI IMAGES
MAMMOGRAPHY AND ITM IMAGES
Mammography accuracy ,[object Object]
The positive predictive value of mammography for breast cancer ranges from 20% in women under age 50 to 60% to 80% in women age 50-69. Randomized clinical trials (RCTs) have demonstrated a 30% reduction in breast cancer mortality in women 50-69 years who are screened annually or biennially with mammograms. (4) The data on women under age 50 are less clear. ,[object Object]
MRI and Ultrasound  The specificity of these techniques are inferior to the mammography and do not increased the sensitivity of the screening
ITM in adjunct to the Mammography Increase the sensitivity of the breast cancer diagnosis  from 20% to 80% for the women under 50 y.o and therefore reduce the number of no necessary biopsies
Intended Uses In Gynecology: The ITM is intended for use as:  Early detection of mastopathy  and monitoring of the mastopathy treatment.  Estimated the lactation function for the pregnant women In Oncology:  The ITM  is intended for use as an adjunct to mammography in patients who have equivocal mammographic findings within ACR BI-RADSTM categories 3 or 4.  This device provides the radiologist with additional information to guide a biopsy recommendation. The device is intended for use on women age > 20 years old and increase the sensitivity of the diagnosis of breast cancer in particular for the women under 50 y.o The system will be use by licensed practitioner and the interpretation will be made by radiologists who have satisfactorily completed the training phase of the ITM system.
Contra Indications None  known to date No Invasive and Safe No Compressive
The ITM Device
ITM Data acquisition sequence Connect first matrix electrode to voltmeter Connect first matrix electrode to current source Inject current and make measurement Last electrode for injecting? No Connect next matrix electrode to current source Yes Last electrode for measuring? Connect next matrix electrode to voltmeter No Result is 65536 pulses In 22 seconds Yes End of measurements
Reconstruction   I L x y E z R Re P(x,y,z) - measured electric intensity - reference electric intensity Electrical impedance tomography with planar array enables imaging of three-dimensional distribution of electrical conductivity in subsurface areas (~ 5-cm depth) using flat matrix of 256 electrodes. For the convenience of viewing, the results are represented as the set of
ITM Calculation of the electric field intensity 1. Finite-difference approximation on staggered grids: x1 2. Two-dimensional linear interpolation of each component: y2 : electrodes : grid, where Exis defined : grid, where Eyis defined position inside corresponding grid cell
The T-Scan 2000 First application  of the Impedance Mammography  The T-Scan™ 2000 is an electrical impedance scanning device that received approval for marketing from the U.S. Food and Drug Administration (FDA) in 1999, with the following labeled indication:  "The T-Scan™ 2000 is intended for use as an adjunct to mammography in patients who have equivocal mammographic finding with ACR Bi-RADS™ categories 3 or 4…”  Electrical impedance studies are used as an adjunct to mammography to improve patient selection for biopsy in patients with equivocal indications..
ITM Versus T-Scan 2000 V V V V V A A A A A A T-Scan measurements ITM measurements V I ~ ~ Image quality is rigidly limited in T-Scan by the physics of the current flow. The collected data set is poor and no data processing is applicable.In ITM system there are no hard limitations of image quality. The number of electrodes, accuracy of measurements and complexity of reconstruction algorithm are limiting factors. The collected data set is full for given geometry of electrodes.

Más contenido relacionado

La actualidad más candente

Quantifying Cardiovascular and Behavioral Correlates of Fear in Mice: Implica...
Quantifying Cardiovascular and Behavioral Correlates of Fear in Mice: Implica...Quantifying Cardiovascular and Behavioral Correlates of Fear in Mice: Implica...
Quantifying Cardiovascular and Behavioral Correlates of Fear in Mice: Implica...InsideScientific
 
Interventional and Surgical Treatment of Valve Disease in Heart Failure Patients
Interventional and Surgical Treatment of Valve Disease in Heart Failure PatientsInterventional and Surgical Treatment of Valve Disease in Heart Failure Patients
Interventional and Surgical Treatment of Valve Disease in Heart Failure PatientsDuke Heart
 
Postural Orthostatic Tachycardia Syndrome – Overview and Focus on Non-Pharmac...
Postural Orthostatic Tachycardia Syndrome – Overview and Focus on Non-Pharmac...Postural Orthostatic Tachycardia Syndrome – Overview and Focus on Non-Pharmac...
Postural Orthostatic Tachycardia Syndrome – Overview and Focus on Non-Pharmac...InsideScientific
 
Out Come Of R
Out Come Of  ROut Come Of  R
Out Come Of Rdrmomusa
 
P2Y12 Inhibition Should not be Started at the Time of NSTEMI Diagnosis - Dr. ...
P2Y12 Inhibition Should not be Started at the Time of NSTEMI Diagnosis - Dr. ...P2Y12 Inhibition Should not be Started at the Time of NSTEMI Diagnosis - Dr. ...
P2Y12 Inhibition Should not be Started at the Time of NSTEMI Diagnosis - Dr. ...Sociedad Española de Cardiología
 
Effects of aspirin for primary prevention in persons with Diabetes mellitus
Effects of aspirin for primary prevention in persons with Diabetes mellitusEffects of aspirin for primary prevention in persons with Diabetes mellitus
Effects of aspirin for primary prevention in persons with Diabetes mellitusShadab Ahmad
 
CT Coronary Angiogram VS Cardiac Stress Test
CT Coronary Angiogram VS Cardiac Stress TestCT Coronary Angiogram VS Cardiac Stress Test
CT Coronary Angiogram VS Cardiac Stress Testahvc0858
 
HRS poster ICDs and ESRD
HRS poster ICDs and ESRDHRS poster ICDs and ESRD
HRS poster ICDs and ESRDMaher Addish
 
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEFSimultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEFDuke Heart
 
Alirocumab and Cardiovascular Outcomes in Patients with Acute Coronary Syndro...
Alirocumab and Cardiovascular Outcomes in Patients with Acute Coronary Syndro...Alirocumab and Cardiovascular Outcomes in Patients with Acute Coronary Syndro...
Alirocumab and Cardiovascular Outcomes in Patients with Acute Coronary Syndro...Sociedad Española de Cardiología
 
ODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACS
ODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACSODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACS
ODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACSMarilyn Mann
 

La actualidad más candente (20)

Quantifying Cardiovascular and Behavioral Correlates of Fear in Mice: Implica...
Quantifying Cardiovascular and Behavioral Correlates of Fear in Mice: Implica...Quantifying Cardiovascular and Behavioral Correlates of Fear in Mice: Implica...
Quantifying Cardiovascular and Behavioral Correlates of Fear in Mice: Implica...
 
Interventional and Surgical Treatment of Valve Disease in Heart Failure Patients
Interventional and Surgical Treatment of Valve Disease in Heart Failure PatientsInterventional and Surgical Treatment of Valve Disease in Heart Failure Patients
Interventional and Surgical Treatment of Valve Disease in Heart Failure Patients
 
Postural Orthostatic Tachycardia Syndrome – Overview and Focus on Non-Pharmac...
Postural Orthostatic Tachycardia Syndrome – Overview and Focus on Non-Pharmac...Postural Orthostatic Tachycardia Syndrome – Overview and Focus on Non-Pharmac...
Postural Orthostatic Tachycardia Syndrome – Overview and Focus on Non-Pharmac...
 
Out Come Of R
Out Come Of  ROut Come Of  R
Out Come Of R
 
P2Y12 Inhibition Should not be Started at the Time of NSTEMI Diagnosis - Dr. ...
P2Y12 Inhibition Should not be Started at the Time of NSTEMI Diagnosis - Dr. ...P2Y12 Inhibition Should not be Started at the Time of NSTEMI Diagnosis - Dr. ...
P2Y12 Inhibition Should not be Started at the Time of NSTEMI Diagnosis - Dr. ...
 
Coca brain martin velarde
Coca brain martin velardeCoca brain martin velarde
Coca brain martin velarde
 
Effects of aspirin for primary prevention in persons with Diabetes mellitus
Effects of aspirin for primary prevention in persons with Diabetes mellitusEffects of aspirin for primary prevention in persons with Diabetes mellitus
Effects of aspirin for primary prevention in persons with Diabetes mellitus
 
CT Coronary Angiogram VS Cardiac Stress Test
CT Coronary Angiogram VS Cardiac Stress TestCT Coronary Angiogram VS Cardiac Stress Test
CT Coronary Angiogram VS Cardiac Stress Test
 
HRS poster ICDs and ESRD
HRS poster ICDs and ESRDHRS poster ICDs and ESRD
HRS poster ICDs and ESRD
 
04 FFR Johnson aimradial2017 - Hyperhemia
04 FFR Johnson aimradial2017 - Hyperhemia04 FFR Johnson aimradial2017 - Hyperhemia
04 FFR Johnson aimradial2017 - Hyperhemia
 
2008.02.12 Massie Hyperlipidemia
2008.02.12    Massie   Hyperlipidemia2008.02.12    Massie   Hyperlipidemia
2008.02.12 Massie Hyperlipidemia
 
Dual Therapy with Aspirin and Rivaroxaban -Dr. Verhamme
Dual Therapy with Aspirin and Rivaroxaban -Dr. VerhammeDual Therapy with Aspirin and Rivaroxaban -Dr. Verhamme
Dual Therapy with Aspirin and Rivaroxaban -Dr. Verhamme
 
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEFSimultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
 
Best practices
Best practicesBest practices
Best practices
 
Improve it
Improve itImprove it
Improve it
 
CONTROVERSIES FOR ASIAN PATIENTS
CONTROVERSIES FOR ASIAN PATIENTSCONTROVERSIES FOR ASIAN PATIENTS
CONTROVERSIES FOR ASIAN PATIENTS
 
Ischemia Trial
Ischemia TrialIschemia Trial
Ischemia Trial
 
Alirocumab and Cardiovascular Outcomes in Patients with Acute Coronary Syndro...
Alirocumab and Cardiovascular Outcomes in Patients with Acute Coronary Syndro...Alirocumab and Cardiovascular Outcomes in Patients with Acute Coronary Syndro...
Alirocumab and Cardiovascular Outcomes in Patients with Acute Coronary Syndro...
 
ODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACS
ODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACSODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACS
ODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACS
 
PCI & AimRadial 2018 | Pd/Pa, iFR and resting gradients: how do they relate? ...
PCI & AimRadial 2018 | Pd/Pa, iFR and resting gradients: how do they relate? ...PCI & AimRadial 2018 | Pd/Pa, iFR and resting gradients: how do they relate? ...
PCI & AimRadial 2018 | Pd/Pa, iFR and resting gradients: how do they relate? ...
 

Similar a Ppt For Esteck Complex For New Broucher Diagnosis

Es Teck Complex presentation
Es Teck Complex presentationEs Teck Complex presentation
Es Teck Complex presentationinov8solutions
 
uptodate on acute kidney injury
uptodate on acute kidney injuryuptodate on acute kidney injury
uptodate on acute kidney injurySherif Mohammed
 
circadian rhythm in Spinal cord injuries
circadian rhythm in Spinal cord injuriescircadian rhythm in Spinal cord injuries
circadian rhythm in Spinal cord injuriesGhizal Fatima
 
Stress testing 2013
Stress testing 2013Stress testing 2013
Stress testing 2013tommarkermd
 
ANS Testing Device University of Miami Study Presentation
ANS Testing Device University of Miami Study PresentationANS Testing Device University of Miami Study Presentation
ANS Testing Device University of Miami Study PresentationMaxiMedRx
 
netra kkkkkkkkkkkkkkkkkkkkkkkkkkkkkkk.pptx
netra kkkkkkkkkkkkkkkkkkkkkkkkkkkkkkk.pptxnetra kkkkkkkkkkkkkkkkkkkkkkkkkkkkkkk.pptx
netra kkkkkkkkkkkkkkkkkkkkkkkkkkkkkkk.pptxManoj Aryal
 
Stich Qol Mark
Stich Qol MarkStich Qol Mark
Stich Qol Markhospital
 
MAD-APE: the Novel Method for Raw Data Processing for both PA and SB, Harri S...
MAD-APE: the Novel Method for Raw Data Processing for both PA and SB, Harri S...MAD-APE: the Novel Method for Raw Data Processing for both PA and SB, Harri S...
MAD-APE: the Novel Method for Raw Data Processing for both PA and SB, Harri S...UKK-instituutti
 
Sr Creatinine estimation journal dr.prathy.pptx
Sr Creatinine estimation journal dr.prathy.pptxSr Creatinine estimation journal dr.prathy.pptx
Sr Creatinine estimation journal dr.prathy.pptxprathyushameravala
 
Yasser's covid 19 discrepancy phenomenon-dr. yasser mohammed hassanain elsayed
Yasser's covid 19 discrepancy phenomenon-dr. yasser mohammed hassanain elsayedYasser's covid 19 discrepancy phenomenon-dr. yasser mohammed hassanain elsayed
Yasser's covid 19 discrepancy phenomenon-dr. yasser mohammed hassanain elsayedYasserMohammedHassan1
 
Actigraphy as a Metric in PAH Research and Clinical Care
Actigraphy as a Metric in PAH Research and Clinical CareActigraphy as a Metric in PAH Research and Clinical Care
Actigraphy as a Metric in PAH Research and Clinical CareDuke Heart
 
Vascular Laboratory: Arterial Physiologic Assessment & Arterial Duplex Scanning
Vascular Laboratory: Arterial Physiologic Assessment & Arterial Duplex ScanningVascular Laboratory: Arterial Physiologic Assessment & Arterial Duplex Scanning
Vascular Laboratory: Arterial Physiologic Assessment & Arterial Duplex ScanningTapish Sahu
 
Analysis of Medication Possession Ratio for Improved Blood Pressure Control
Analysis of Medication Possession Ratio for Improved Blood Pressure ControlAnalysis of Medication Possession Ratio for Improved Blood Pressure Control
Analysis of Medication Possession Ratio for Improved Blood Pressure ControlHealth Informatics New Zealand
 
2009artandscienceofhemodynamicmonitoringfewphotos (1)
2009artandscienceofhemodynamicmonitoringfewphotos (1)2009artandscienceofhemodynamicmonitoringfewphotos (1)
2009artandscienceofhemodynamicmonitoringfewphotos (1)cjani
 
2009artandscienceofhemodynamicmonitoringfewphotos
2009artandscienceofhemodynamicmonitoringfewphotos2009artandscienceofhemodynamicmonitoringfewphotos
2009artandscienceofhemodynamicmonitoringfewphotoscjani
 

Similar a Ppt For Esteck Complex For New Broucher Diagnosis (20)

Es Teck Complex presentation
Es Teck Complex presentationEs Teck Complex presentation
Es Teck Complex presentation
 
68 132
68 13268 132
68 132
 
uptodate on acute kidney injury
uptodate on acute kidney injuryuptodate on acute kidney injury
uptodate on acute kidney injury
 
circadian rhythm in Spinal cord injuries
circadian rhythm in Spinal cord injuriescircadian rhythm in Spinal cord injuries
circadian rhythm in Spinal cord injuries
 
Cdmjc cole4
Cdmjc cole4Cdmjc cole4
Cdmjc cole4
 
Stress testing 2013
Stress testing 2013Stress testing 2013
Stress testing 2013
 
ANS Testing Device University of Miami Study Presentation
ANS Testing Device University of Miami Study PresentationANS Testing Device University of Miami Study Presentation
ANS Testing Device University of Miami Study Presentation
 
netra kkkkkkkkkkkkkkkkkkkkkkkkkkkkkkk.pptx
netra kkkkkkkkkkkkkkkkkkkkkkkkkkkkkkk.pptxnetra kkkkkkkkkkkkkkkkkkkkkkkkkkkkkkk.pptx
netra kkkkkkkkkkkkkkkkkkkkkkkkkkkkkkk.pptx
 
Most Advance Portable Body Analyzer
Most Advance Portable Body AnalyzerMost Advance Portable Body Analyzer
Most Advance Portable Body Analyzer
 
Stich Qol Mark
Stich Qol MarkStich Qol Mark
Stich Qol Mark
 
BESTIPP_Polio_Study
BESTIPP_Polio_StudyBESTIPP_Polio_Study
BESTIPP_Polio_Study
 
MAD-APE: the Novel Method for Raw Data Processing for both PA and SB, Harri S...
MAD-APE: the Novel Method for Raw Data Processing for both PA and SB, Harri S...MAD-APE: the Novel Method for Raw Data Processing for both PA and SB, Harri S...
MAD-APE: the Novel Method for Raw Data Processing for both PA and SB, Harri S...
 
Sr Creatinine estimation journal dr.prathy.pptx
Sr Creatinine estimation journal dr.prathy.pptxSr Creatinine estimation journal dr.prathy.pptx
Sr Creatinine estimation journal dr.prathy.pptx
 
Yasser's covid 19 discrepancy phenomenon-dr. yasser mohammed hassanain elsayed
Yasser's covid 19 discrepancy phenomenon-dr. yasser mohammed hassanain elsayedYasser's covid 19 discrepancy phenomenon-dr. yasser mohammed hassanain elsayed
Yasser's covid 19 discrepancy phenomenon-dr. yasser mohammed hassanain elsayed
 
Actigraphy as a Metric in PAH Research and Clinical Care
Actigraphy as a Metric in PAH Research and Clinical CareActigraphy as a Metric in PAH Research and Clinical Care
Actigraphy as a Metric in PAH Research and Clinical Care
 
Vascular Laboratory: Arterial Physiologic Assessment & Arterial Duplex Scanning
Vascular Laboratory: Arterial Physiologic Assessment & Arterial Duplex ScanningVascular Laboratory: Arterial Physiologic Assessment & Arterial Duplex Scanning
Vascular Laboratory: Arterial Physiologic Assessment & Arterial Duplex Scanning
 
Analysis of Medication Possession Ratio for Improved Blood Pressure Control
Analysis of Medication Possession Ratio for Improved Blood Pressure ControlAnalysis of Medication Possession Ratio for Improved Blood Pressure Control
Analysis of Medication Possession Ratio for Improved Blood Pressure Control
 
2009artandscienceofhemodynamicmonitoringfewphotos (1)
2009artandscienceofhemodynamicmonitoringfewphotos (1)2009artandscienceofhemodynamicmonitoringfewphotos (1)
2009artandscienceofhemodynamicmonitoringfewphotos (1)
 
2009artandscienceofhemodynamicmonitoringfewphotos
2009artandscienceofhemodynamicmonitoringfewphotos2009artandscienceofhemodynamicmonitoringfewphotos
2009artandscienceofhemodynamicmonitoringfewphotos
 
Strive Teleconf Presentation Apr11 2007
Strive Teleconf Presentation Apr11 2007Strive Teleconf Presentation Apr11 2007
Strive Teleconf Presentation Apr11 2007
 

Ppt For Esteck Complex For New Broucher Diagnosis

  • 2. Welcome to LD TECHNOLOGY We are listening the body signals < < <
  • 3. Medical devices Positioning Diagnosis /Monitoring GENERAL INFORMATION’S ACCURACY
  • 4. DIAGNOSIS DEFINITION* Diagnosis is the identification, by process of elimination, of the nature of anything. *Wikipedia
  • 5.
  • 7. In vivo Physiological measurements.Physician’s Knowledge and interpretation
  • 8.
  • 9. A medical device do not make a diagnosis, only a Physician can make a diagnosis.
  • 10. According to the investigation site, each medical device is providing specific indicators in same or different direction.
  • 11.
  • 13. Diagnosis are hypothesis After the process of elimination , the cross analysis of the clinical context and supplementary examinations , the physician make a hypothesis of diagnosis: because the human body is a complex of balance and all the dysfunctions or diseases have implications in all the body systems
  • 14. Treatment choice Hypothesis of diagnostic Adapted Treatment of the diagnosed diseases issues from the clinical investigations Improvement of the results of the supplementary examinations No Improvement of the results of the supplementary examinations MONITORING Improvement of the clinical context Or Improvement or no improvement of the clinical context Side effect over the benefits of the treatment No validation , misdiagnosis or no responses dues to inter individual difference Validation of the diagnosis hypothesis
  • 15. EIS SYSTEM TECHNOLOGY FEATURES BACKGROUND
  • 17.
  • 18. I.S.F Ionic concentration and in particular the Na+ concentration
  • 19. Blood flow Conductivity measurement accuracy +/-3.5% 2. Modeling** of the Human body according to the conductivity of the 22 segments by mathematical application of the Venn diagram and the normal positioning extrapolation of the body systems. **Accuracy of the modeling ( p<0.001) for the cerebral frontal lobes, digestive system Prostate and thyroid.
  • 20. EIS Features Sequence of the measurement of the 22 body segments ESG graphic: conductivity of the 22 segments ESG normal range values
  • 21. EIS Features (2) Min C O N D U C T I V I T Y Venn diagram calculation Max Modeling Maxwell equation’ s calculation
  • 22. EIS / EFFECT OF THE DC CURRENT IN INTERSTITIAL FLUID Na+ The current is carrier by the ions . The Current is sending from the Anode (+) to Cathode (-) , and therefore the Na+ ( most significant concentration of positive ions in the IF) are moving to the negative pole . The conductivity is proportionally increased with the Na+ concentration and the volume of the interstitial fluid Na+ Na+ Na+ Na+ 1.28 V
  • 23. Na+/K+ pump Na+/H+ anti porterNa+/ATP Production Na+ Na+ Na+ Na+ Na+ H+ Na+ Na+ Na+ Na+ Na+ ATP
  • 24. Interstitial fluid volume and Oxygen delivery Effect of inter capillary distance on relation between oxygen delivery BMJ. 1998 November 14; 317(7169): 1370–1373. Copyright © 1998, British Medical Journal
  • 25.
  • 26. EIS –BF SYSTEM CLINICAL INVESTIGATIONS UPDATE VERSION 10
  • 27. EIS- BF Clinical Investigations Accuracy for Monitoring of the following treatment (p< 0.001) : Sp 94% No sensitivity Thyroid substitute treatment Hypo tensors ( Beta blockers and CEI) Anticoagulants Antidepressants SSRI Accuracy in Adjunct in conventional diagnosis of the ADHD children: (p< 0.0001) : Sp 95% / Se 78%
  • 28. Visit 1 : No treatment Visit 2: Dosage 100 µg Visit 3: Dosage 120 µg Visit 4: Dosage 150 µg Visit 5: Dosage 100 µg Thyroid value in EIS Modeling Visit 1 :-40 Visit 2: -10 Visit 3: 0 Visit 4: +20 Visit 5: -5 N=52 (r=0.79, P<0.001, and r=0.80, P<0.001, respectively). TSH measured in lab tests Visit 1 Visit 2: 6 Visit 3: 3 Visit 4: 0 Visit 5: 2 N=52 (r=0.81, P<0.001, and r=0.73, P<0.001, respectively).
  • 29. N=52 (r=0.79, P<0.001, and r=0.80, P<0.001,). N=52 (r=0.79, P<0.001, and r=0.80, P<0.001,).
  • 30. N=52 (r=0.79, P<0.001, and r=0.80, P<0.001,). N=52 (r=0.79, P<0.001, and r=0.80, P<0.001,).
  • 31. N=52 (r=0.79, P<0.001, and r=0.80, P<0.001,). N=52 (r=0.79, P<0.001, and r=0.80, P<0.001,).
  • 32.
  • 34. EIS BF Results Version 10
  • 41. Uro genital and renal indicators
  • 42. Follow up of all the indicators
  • 44. Antidepressant (SSRI) Follow up Before treatment Response No response
  • 45. Follow up of the Cerebral neurotransmitters
  • 47. Follow up of thyroid treatment Monitoring and results Before treatment Over doses Under doses
  • 49. Anti agregants and anticoagulants follow up Before treatment Effective treatment No effective
  • 51. Beta blockers follow up Before treatment No effective treatment Overdosis and side effects Good treatment
  • 52. CEI Follow up Before treatment Good treatment Overdose and side effect No effective
  • 53. ADHD Children profile and diagnosis in adjunct with the clinical context
  • 54. Indicator of ADHD Children Lack Dopamine and Serotonin and signs and symptoms from clinical context children less 17 y.o
  • 55. EIS POSITIONING QUALITY SYSTEM IN MEDECINE
  • 56. EIS System: May be a possibility for help the quality system requirements in medicine
  • 57. Positioning of the EIS in the Quality System Requirements EIS SYSTEM ADHD
  • 58.
  • 59. For the patient : Understanding of the treatment and goal of the treatment
  • 60. For the practitioner Early visualization of the therapies and early possibility of corrective action
  • 61. Because a disease treatment requires drug, sometime surgery and always lifestyle change
  • 62.
  • 64. Better understanding of the intended use and side effects of the treatments used
  • 65. Corrective actions that the patient can understand
  • 67.
  • 68. New products EIS BWS: Wellness and lifestyle ES Teck: Estimated of the ANS activity and of cardiovascular indicators. 510k in progress Nr K083229 ES Teck Complex : Combination EIS /ES Teck ITM Breast imaging by electro impedance.
  • 69. EIS New application : BSW (Body Scan Wellness) Why BSW? Because There is not good or bad diet for every people, there is good or bad diet for each person The change of nutrition need to be monitoring and the good nutrition for each person is not available all his life. Based on the EIS and BC device measurement
  • 70. Why the E S Teck Because HRV ( ANS activity estimation) Photoelectrical Plethysmograph ( Vascular estimation) body composition and the phase Angle measurement Can give new indicators in the process of elimination of the physician’s diagnosis
  • 71. Why the ES Teck Complex Combination of the EIS and the ES Teck: Because : The cross analysis of the indicators issue from 4 different technologies will increase the sensitivity and therefore the accuracy of a medical device
  • 72.
  • 73. The positive predictive value of mammography for breast cancer ranges from 20% in women under age 50.
  • 74. The tissue conductivity has a high sensitivity (> 80%) for the cancer.
  • 75.
  • 79. Nutritional and micro nutrional program Analysis
  • 80. Nutritional Analysis ReportAll results should be considered in the clinical context of the patient's case history, symptoms, known diagnosis, current medications, treatment plan and therapies. This diet analysis does not replace the advice of your practitioner.The estimated body composition is made according to the James equation and the formulas from the peer reviews.
  • 83. ES TECK SYSTEM GENERAL INFORMATION’S
  • 84. ES Teck System (Cardiology) HRV Photoelectrical Plethysmograph
  • 85. HRV ( short time) HRV Reference: Task Force of The European Society of Cardiology and The North American Society of Pacing and Electrophysiology (1996)
  • 86.
  • 87. Takazawa, Kenji; Tanaka, Nobuhiro; Fujita, Masami; Matsuoka, Osamu; Saiki, Tokuyu; Aikawa, Masaru; Tamura, Sinobu; Ibukiyama, Chiharu :Assessment of Vasoactive Agents and Vascular Aging by the Second Derivative of Photoplethysmogram Waveform Hypertension: Volume 32(2)August 1998pp 365-370
  • 88. IToshiaki OTSUKA , Tomoyuki KAWADA , Masao KATSUMATA , Chikao IBUKI , and Yoshiki KUSAMA ndependent Determinants of Second Derivative of the Finger Photoplethysmogram among Various Cardiovascular Risk Factors in Middle-Aged Men Hypertens Res Vol. 30, No. 12 (2007)
  • 89. Toshiaki Otsuka, , Tomoyuki Kawada, Masao Katsumata,ChikaoIbuki, :Utility of Second Derivative of the Finger Photoplethysmogram for the Estimation of the Risk of Coronary Heart Disease in the General Population Circ J 2006; 70: 304 – 310
  • 90. Alberto Avolio: The finger volume pulse and assessment of arterial properties .Journal of Hypertension 2002, 20:2341–2343
  • 91.
  • 92.  Heart Rate and sinus node depolarization
  • 93. Autonomic Nervous System and Heart rate variability
  • 94. SpO2 AND Photoelectrical Plethysmography SpO2 Probe Infra red/ Red 660/905 nm Photo diode SpO2% PR Vascular waves
  • 95. SpO2 ANALYSIS Oxygen - hemoglobin Affinity Changes. The functions of hemoglobin are oxygen pickup and delivery. The hemoglobin has an affinity (the strength of bond between oxygen and hemoglobin) that can be increased or decreased due to various situations. If hemoglobin has an increased affinity, it is highly saturated; but oxygen is less available for release to the tissues due to the strong bond. The reverse is also true.
  • 97. Analysis by Acceleration and Second derivative
  • 98. Analysis of the Second derivative with age
  • 99. Analysis of the second derivative and diseases : b/a
  • 100. Analysis of the second derivative and diseases : d/a
  • 101. Specificity and sensitivity of the b/a and d/a indicators
  • 102. Specificity and sensitivity of the b/a and d/a indicators Ref. Toshiaki OTSUKA , Tomoyuki KAWADA , Masao KATSUMATA , Chikao IBUKI , and Yoshiki KUSAMA Independent Determinants of Second Derivative of the Finger Photoplethysmogram among Various Cardiovascular Risk Factors in Middle-Aged Men Hypertens Res Vol. 30, No. 12 (2007)
  • 103. Results of ES Teck
  • 104. HRV STATISTICAL RESULTS
  • 105. SpO2 and Photoelectrical Plethysmograph results
  • 106. E.S TECK COMPLEX GENERAL INFORMATION’S
  • 107. ES TECK COMPLEX THE NATURAL EIS UPDATE
  • 108. ES Teck Complex Measurements
  • 110.
  • 111. It only provides numerical analyses of the input electrocardiogram.
  • 112. Estimate of the parasympathetic and sympathetic system stimulation.
  • 113. PP module: Analyze the pulse waveform by photoelectric plethysmography and Pulse rate.
  • 114. Evaluation of Large and small artery
  • 116. Monitoring of diseases, functional and lifestyle ‘ treatments
  • 117. Adjunct to conventional diagnosis of ADHD children
  • 119.
  • 120. Resistance and Reactance measurements Resistance is a measure of how difficult it is for electricity to flow through an object. Reactance Most objects have some capacitance, which is a measure of ability to store an electrical charge. The more capacitance the object has, or the faster the current changes direction, the less the object will “react” to the current.  
  • 121.
  • 123. Impedance Components Phase Angle Xc = 1 / (2 * PI * F * C), C – Capacity [Farad] Phase Angle = Arctan (Xc / R)
  • 124. Clinical application in survival in colorectal cancer The survival curves for the 2 categories of phase angle areshown. Patients with a phase angle < 5.57 had a mediansurvival of 8.6 mo (95% CI: 4.8, 12.4; n = 26), and those witha phase angle > 5.57 had a median survival of 40.4 mo (95%CI: 21.9, 58.8; n = 26); this difference was significant (P= 0.0001).
  • 125.
  • 126. Impact of phase angle in liver cirrhosis
  • 133. SpO2 RESULTS AND MANAGEMENT OF THE PHOTOELECTRICAL WAVE
  • 135. Vascular Indicators PH : Relation with blood flow of small artery EEI : Relation with LV ejection and elasticity of large artery - LV Ejection Insufficiency DDI : Relation with contraction and tension of small artery - Hypertension & Arteriosclerosis DEI : Relation with blood flow to vein system. Etc (Estimated Cardiac Ejection time) : 260~380  Function of left ventricle
  • 138.
  • 139.
  • 145. UROGENITAL AND RENAL INDICATORS
  • 146. Follow up of all the indicators
  • 147. Follow up of the Cerebral neurotransmitters
  • 152. ADHD Children profile and diagnosis in adjunct with the clinical context
  • 153. Chiropractor Indicators and monitoring treatment
  • 154. Advices for Lifestyle and exercises and monitoring
  • 155. Advices for Lifestyle and exercises and monitoring
  • 156. Advices for Lifestyle and exercises and monitoring
  • 158. Sport men condition Evaluation and improvement
  • 159. Statistical risk analysis No access before 5 measurements. The accuracy increased with the number of measurements. Statistical analysis of the indicators of each body systems and metabolic general indicators It is not a diagnosis , but help for the physician in the process of elimination
  • 160. I.T.M Impedance Tomography Mammography GENERAL INFORMATION’S
  • 161. ITM ADJUNCT TO THE MAMMOGRAPHY BI-RADS
  • 162. MAMOGRAPHY IMAGES AND MRI IMAGES
  • 164.
  • 165.
  • 166. MRI and Ultrasound The specificity of these techniques are inferior to the mammography and do not increased the sensitivity of the screening
  • 167. ITM in adjunct to the Mammography Increase the sensitivity of the breast cancer diagnosis from 20% to 80% for the women under 50 y.o and therefore reduce the number of no necessary biopsies
  • 168. Intended Uses In Gynecology: The ITM is intended for use as: Early detection of mastopathy and monitoring of the mastopathy treatment. Estimated the lactation function for the pregnant women In Oncology: The ITM is intended for use as an adjunct to mammography in patients who have equivocal mammographic findings within ACR BI-RADSTM categories 3 or 4. This device provides the radiologist with additional information to guide a biopsy recommendation. The device is intended for use on women age > 20 years old and increase the sensitivity of the diagnosis of breast cancer in particular for the women under 50 y.o The system will be use by licensed practitioner and the interpretation will be made by radiologists who have satisfactorily completed the training phase of the ITM system.
  • 169. Contra Indications None known to date No Invasive and Safe No Compressive
  • 171. ITM Data acquisition sequence Connect first matrix electrode to voltmeter Connect first matrix electrode to current source Inject current and make measurement Last electrode for injecting? No Connect next matrix electrode to current source Yes Last electrode for measuring? Connect next matrix electrode to voltmeter No Result is 65536 pulses In 22 seconds Yes End of measurements
  • 172. Reconstruction   I L x y E z R Re P(x,y,z) - measured electric intensity - reference electric intensity Electrical impedance tomography with planar array enables imaging of three-dimensional distribution of electrical conductivity in subsurface areas (~ 5-cm depth) using flat matrix of 256 electrodes. For the convenience of viewing, the results are represented as the set of
  • 173. ITM Calculation of the electric field intensity 1. Finite-difference approximation on staggered grids: x1 2. Two-dimensional linear interpolation of each component: y2 : electrodes : grid, where Exis defined : grid, where Eyis defined position inside corresponding grid cell
  • 174. The T-Scan 2000 First application of the Impedance Mammography The T-Scan™ 2000 is an electrical impedance scanning device that received approval for marketing from the U.S. Food and Drug Administration (FDA) in 1999, with the following labeled indication: "The T-Scan™ 2000 is intended for use as an adjunct to mammography in patients who have equivocal mammographic finding with ACR Bi-RADS™ categories 3 or 4…” Electrical impedance studies are used as an adjunct to mammography to improve patient selection for biopsy in patients with equivocal indications..
  • 175. ITM Versus T-Scan 2000 V V V V V A A A A A A T-Scan measurements ITM measurements V I ~ ~ Image quality is rigidly limited in T-Scan by the physics of the current flow. The collected data set is poor and no data processing is applicable.In ITM system there are no hard limitations of image quality. The number of electrodes, accuracy of measurements and complexity of reconstruction algorithm are limiting factors. The collected data set is full for given geometry of electrodes.
  • 176. ITM Versus T-Scan 2000 8 images for each breast and only 2 depth slides. 42 electrodes and 2 frequencies 1 image for each breast and 7 depth slides . 256 electrodes and 7 frequencies
  • 177.
  • 178.
  • 179.
  • 181. BREAST NORMAL RANGE OF CONDUCTIVITY
  • 182. ITM Clinical investigation protocol performed in accordance with trial protocol approved by the Western Institutional Review Board (WIRB) in Olympia, Washington
  • 183.
  • 184.
  • 185. Specificity = Mammography + ITM diagnosis is malignant | Biopsy is malignant) = 13/14 = 0.926Specificity = only Radiology diagnosis is malignant | Biopsy is malignant) = 13/14 = 0.926Note that the specificity for malignant biopsy (cancer) is the same for both Mammography + ITM and diagnostic only radiology.Sensitivity Mammography + ITM diagnosis is benign | Biopsy is benign) = 17/26 = 0.654 Similarly, the conditional probability that defines specificity for diagnostic radiology is as follows: Sensitivity only Radiology diagnosis is benign | Biopsy is benign) = 3/26 = 0.115
  • 189. Mastopathy : Multiple cysts of the left and the right breasts
  • 190. Multiple cysts of the left and the rights breasts
  • 192. Left Breast Cancer : Conductivity analysis
  • 200. Contract of MaintenanceFree the first yearAnd then US$ 500 / Year If no maintenance contract : Update price : US$ 400Each technical support intervention: US$ 80
  • 202. BILLING SYSTEM NETWORK